Investment Thesis
Hawkins demonstrates solid operational fundamentals with strong free cash flow ($86.1M) and healthy liquidity (2.21x current ratio), but the extreme revenue growth of 8123% coupled with declining net income (-3.3%) signals either temporary integration disruption from a major acquisition or concerning margin compression requiring investigation before conviction.
Strengths
- Strong free cash flow generation of $86.1M with 7.9% FCF margin demonstrates underlying operational capability
- Healthy liquidity profile with 2.21x current ratio and conservative debt-to-equity ratio of 0.46x
- Positive profitability metrics with 7.5% net margin and respectable ROE of 15.3% despite growth headwinds
Risks
- Severe revenue-profit disconnect: 8123% revenue growth versus -3.3% net income decline suggests either undisclosed acquisition integration costs, margin compression, or accounting anomalies requiring clarification
- Critically low cash position of $3.9M relative to $244M long-term debt and company size raises working capital concerns in chemical wholesale sector
- Sustained profitability decline year-over-year contradicts growth narrative and may indicate structural margin pressure rather than temporary costs
Key Metrics to Watch
- Net margin trend in next two quarters - determine if income decline is reversing or structural
- Cash position and working capital requirements - resolve the apparent cash adequacy concern
- Operating cash flow sustainability - verify the $144.3M OCF can be maintained post-integration
Financial Metrics
Revenue
1.1B
Net Income
81.5M
EPS (Diluted)
$3.91
Free Cash Flow
86.1M
Total Assets
986.3M
Cash
3.9M
Profitability Ratios
Gross Margin
22.6%
Operating Margin
11.2%
Net Margin
7.5%
ROE
15.3%
ROA
8.3%
FCF Margin
7.9%
Balance Sheet & Liquidity
Current Ratio
2.21x
Quick Ratio
1.46x
Debt/Equity
0.46x
Debt/Assets
45.9%
Interest Coverage
N/A
Long-term Debt
244.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-15T09:28:24.988236 |
Data as of: 2026-03-29 |
Powered by Claude AI